ℹ️
🇬🇧
Search
Search for publications relevant for "idh2"
idh2
Publication
Class
Person
Publication
Programmes
publication
Biochemical Background in Mitochondria Affects 2HG Production by IDH2 and ADHFE1 in Breast Carcinoma
2021 |
First Faculty of Medicine
publication
"Study of molecular predictors of patients with: 1. glioma tumors 2. non small cell lung cancer"
Publication without faculty affiliation
publication
Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
2015 |
Faculty of Physical Education and Sport, First Faculty of Medicine
publication
IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
2018 |
Faculty of Medicine in Hradec Králové
publication
SIRT3 and GCN5L regulation of NADP+- and NADPH-driven reactions of mitochondrial isocitrate dehydrogenase IDH2
2020 |
First Faculty of Medicine
publication
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model
2012 |
Second Faculty of Medicine
publication
Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients
2021 |
First Faculty of Medicine
publication
Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again-A Historical Perspective
2020 |
Faculty of Medicine in Pilsen
publication
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
2020 |
Second Faculty of Medicine
publication
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene
2015 |
First Faculty of Medicine
publication
Anaplastic Oligodendrogliomas - the Age of Personalized Medicine Has Arrived?
2014 |
Faculty of Medicine in Pilsen
publication
Biomarkers in Head and Neck Carcinomas
2022 |
Faculty of Medicine in Pilsen
publication
Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
2014 |
Faculty of Medicine in Pilsen
publication
Background Levels of Neomorphic 2-hydroxyglutarate Facilitate Proliferation of Primary Fibroblasts
2017 |
Faculty of Physical Education and Sport, First Faculty of Medicine
publication
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters
2022 |
Faculty of Pharmacy in Hradec Králové
publication
IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
2018 |
Faculty of Medicine in Pilsen